Arcus Biosciences (RCUS) Interest Coverage Ratio (2023 - 2026)
Arcus Biosciences (RCUS) posted quarterly Interest Coverage Ratio of 44.67 for Q1 2026, up 26.78% year-over-year from 35.23 in Q1 2025, and up 60.82% quarter-over-quarter from 114.0 in Q4 2025.
Powered by 
Analysis
Arcus Biosciences (RCUS) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
Arcus Biosciences' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 44.67 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 26.78% year-over-year to 44.67; the TTM figure through Mar 2026 stood at 44.22 (up 69.57% YoY), while the FY2025 annual figure was 0.94, up 10.29% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 44.67, up from 114.0 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 103.0 in Q4 2024, with the low at 114.0 in Q4 2025.
- The 5-year median for Interest Coverage Ratio is 20.75 (2023), against an average of 26.59.
- The sharpest annual moves came in 2023 and 2024: Interest Coverage Ratio jumped 530.41% in 2023, then tumbled 410.84% in 2024.
- Arcus Biosciences' Interest Coverage Ratio stood at 10.57 in 2022, then surged by 530.41% to 45.5 in 2023, then soared by 126.37% to 103.0 in 2024, then slumped by 210.68% to 114.0 in 2025, then surged by 60.82% to 44.67 in 2026.
- Business Quant data shows RCUS's Interest Coverage Ratio at 44.67 in Q1 2026, 114.0 in Q4 2025, and 35.5 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.87 Bn | 131.01 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.57 Bn | 77.57 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.19 Bn | 53.05 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.07 Bn | 44.07 Bn | - | -21.24 |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.38 Bn | 32.07 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | 1.42 |
| 9 | Insmed | 27.41 Bn | 26.25 Bn | 358.27 Mn | -0.08 |
| 10 | Arcus Biosciences | 3.73 Bn | 3.03 Bn | - | -32.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -32.00 |
| Mar 31, 2026 | -44.67 |
| Dec 31, 2025 | -57.00 |
| Sep 30, 2025 | -47.33 |
| Jun 30, 2025 | -4.00 |
| Mar 31, 2025 | -122.00 |
| Dec 31, 2024 | -51.50 |
| Sep 30, 2024 | -105.00 |
| Mar 31, 2024 | -16.00 |
| Sep 30, 2023 | -80.00 |